Roswell Park Comprehensive Cancer Center has received the following certifications, designations and awards:
US News & World Report Best Hospital
Roswell Park Comprehensive Cancer Center has been named a 2017–18 Best Hospital for cancer by U.S. News & World Report. The Buffalo, N.Y., comprehensive cancer center was ranked by the news outlet as 33rd among nearly 900 cancer hospitals reviewed nationwide, and was also recognized as high-performing within two other categories: urology and lung cancer surgery.
Becker's Hospital Review: 100 Hospitals and Health Systems with Great Oncology Programs
Becker’s Hospital Review compiles an annual list of centers that are national leaders in patient care, cancer outcomes and research. In selecting facilities for its “Great Oncology Programs” feature, the Becker’s editorial team analyzed data from such sources as U.S. News & World Report, HealthGrades, Thomson Reuters, the National Cancer Institute, the American College of Surgeons and the American Nurses Credentialing Center.
Blue Distinction Center for Blood and Marrow Transplants
Roswell Park Comprehensive Cancer Center is one of three centers in New York State, and only 100 nationwide, to be designated a Blue Distinction® Center for Transplants by the BlueCross BlueShield Association (BCBSA). Blue Distinction Centers deliver quality specialty care based on objective, transparent measures for patient safety and health outcomes that were developed with input from the medical community.
Commission on Cancer
Established by the American College of Surgeons (ACoS) in 1922, the multidisciplinary Commission on Cancer establishes standards to ensure quality, multidisciplinary, and comprehensive cancer care delivery in health care settings; conducts surveys in health care settings to assess compliance with those standards; collects standardized data from CoC-accredited health care settings to measure cancer care quality; uses data to monitor treatment patterns and outcomes and enhance cancer control and clinical surveillance activities, and develops effective educational interventions to improve cancer prevention, early detection, cancer care delivery, and outcomes in health care settings.
Guardian of Excellence by Press Ganey
Roswell Park is a 2017 Press Ganey Guardian of Excellence Award winner in the area of Patient Experience. Guardian of Excellence awards recognize healthcare organizations that have consistently performed in the 95th percentile or above in a particular area of operations.
Joint Commission Accreditation
A hospital needs to be an accredited Institution in the eyes of CMS to be eligible for reimbursement for Medicaid reimbursement. The Joint Commission is a regulatory body that provides this eligibility to hospitals, and does so by confirming that the hospital is practicing in a manner that is safe for their patients. This is a process which includes an annual review of standards, and every third year an intensive survey is conducted where Joint Commission surveyors conduct an on-site review that covers all levels of care that can impact a patient. This includes but is not limited to, the hospital’s building being up to code for fire safety, proper documentation and care being received by patients and even reviewing policies and procedures of the Institution.
Joint Commission Palliative Care Certification
A new program being offered through the Joint Commission, Roswell Park was an early adopter of the Palliative Care Certification, completing this certification shortly after it was offered in 2011. The Palliative Care Program at Roswell Park is one that engages patients throughout their care, allowing for the patient and their family to be actively involved in the choices for their care. These choices include but are not limited to symptom management when undergoing treatment, choosing the path of care that best matches the patient’s wishes and planning for end of life care, whenever that arises. This certification is achieved by yearly monitoring and a bi-annual on-site visit where a Joint Commission surveyor reviews the program.
NCI Designated Comprehensive Cancer Center
Roswell Park is among the first cancer centers in the country to be designated a “Comprehensive Cancer Center” by the National Cancer Institute (NCI), and has held that distinction without interruption since 1974. We are the only NCI-designated Comprehensive Cancer Center in Upstate New York, and one of only 47 in the entire nation. We are one of 69 Nationally Designated Cancer Centers through the NCI. This means that we are one of a select few hospitals which can translate the latest scientific knowledge into the cutting edge cancer treatments of tomorrow. Simply put, this designation allows for newer treatments to be available to patients that do not exist in the regular community hospital setting.
National Comprehensive Cancer Network
The National Comprehensive Cancer Network (NCCN) is a not-for-profit alliance of 27 of the nation’s leading cancer centers. Experts from NCCN Member Institutions diagnose and treat all cancers, particularly complex, aggressive or uncommon cancers. More than 160,000 new patients receive cancer care at NCCN Member Institutions over the course of each year. Thirty-eight Nobel Prize winners have served on the faculties of NCCN Member Institutions. Many Roswell Park faculty serve on the NCCN panels that create the Clinical Practice Guidelines in Oncology, the internationally recognized standards for clinical policy in oncology, and the most comprehensive, most frequently updated clinical practice guidelines available in any area of medicine. Read the Roswell Park NCCN Member Institution Profile.
Partnership for Patients
Roswell Park participates in the Partnership for Patients, which is a group of 4,000 participating hospitals that focus on making care safer for their patients. This group shares best practices to help participating hospitals attempt to decrease things such as, adverse drug events, Catheter-Associated Urinary Tract Infections, Central Line Blood Stream Infections, Injuries from Falls and Pressure Ulcers, among others. The Partnership is looking for this collaboration to decrease preventable hospital acquired conditions by 20 percent by the end of 2017 when compared to 2014.